Investor relations

Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The company is committed to improving patient welfare and outcomes, increasing clinical data accuracy, and promoting positive health economics.

Observe Medical is listed on Euronext Oslo under OBSRV.

Read our latest regulatory news

Observe Medical ASA: Registration of new share capital

Oslo, 20 October 2025 Reference is made to the announcement by Observe Medical ASA (the "Company" or "Observe Medical", OSE ticker "OBSVR") on 13 October 2025 regarding the final result of the subsequent offering in the Company, where a total of 24,000,000 new shares were subscribed and allocated at a subscription price of NOK 0.50…

Read more

Observe Medical ASA: Registration of new share capital

Oslo, 16 October 2025 Reference is made to the announcement by Observe Medical ASA (the "Company" or "Observe Medical", OSE ticker "OBSVR") on 10 October 2025 regarding the extraordinary general meeting's resolution to increase the share capital of the Company by the issuance of 20,000,000 new shares to Songa Capital AS and four affiliated companies in…

Read more

Reports and presentations

Prospectus

Financial calendar

  • 18 March 2025

    Second Half and Full Year 2024 results

  • 30 April 2025

    Annual Report 2024

  • 27 June 2025

    Annual General Meeting

  • 29 August 2025

    First Half Year 2025 Report

The Share

Share performance

Follow the development of the Observe Medical share at Oslo Stock Exchange under the OBSRV ticker. Observe Medical ASA has been listed on the Oslo Stock Exchange since November 4, 2019.

To view all stock exchange releases form the Company, please review Oslo Stock Exchange NewsWeb under the OBSRV ticker.

Shareholders

As at 23 October 2025

NameNumber of shares% of top 20% of total Country
1

NAVAMEDIC ASA

12 564 279

13.13%

9.23%

Norway
2

R INVESTMENT COMPANY AS

10 703 684 

11.19%

7.86%

Norway
3

SONGA CAPITAL AS

10 000 000 

10.45%

7.35%

Norway
4

JPB AS

7 170 996 

7.50%

5.27%

Norway
5

KING KONG INVEST AS

6 333 333  

6.62%

4.65%

Norway
6

JIANGSU HONGXIN MEDICAL TECHNOLO

6 000 000 

6.27%

4.41%

CHINA

7

SEED CAPITAL AS

5 236 268 

5.47%

3.85%

NORWAY

8

ABAGUST AS

5 000 000 

5.23%

3.67%

Norway
9

BJØRNTVEDT, VEGARD

4 063 648 

4.25%

2.98%

Norway
10

RO, LARS

4 004 004 

4.19%

2.94%

Norway
11

EIDCO AS

4 000 000 

4.18%

2.94%

Norway
12

GLIMT INVEST AS

3 005 113 

3.14%

2.21%

NORWAY

13

EM KAPITAL AS

3 000 000 

3.14%

2.20%

Norway

14

F2 FUNDS AS

2 576 159 

2.69%

1.89%

Norway
15

JJB AS

2 100 000 

2.19%

1.54%

Norway
16

AKB AS

2 100 000 

2.19%

1.54%

Norway
17

SONGA X AS

2 100 000 

2.19%

1.54%

Norway
18

AGMABLY AS

2 100 000 

2.19%

1.54%

Norway
19

SILVERCOIN INDUSTRIES AS

2 000 000 

2.09%

1.47%

Norway
20

GINNY INVEST AS

1 616 666 

1.69%

1.19%

Norway
Total number owned by top 20

95 674 150 

100.00%

70.27%

Total number of shares

136 146 333 


Total number of shareholders

2 286

Basic share data

Stock Exchange:

Ticker:

First day of listing:

Sector:

Trading Currency:

ISIN:

Number of shares issued:

Nominal value:

Euronext Expand Oslo

OBSRV

4 November 2019

Healthcare

NOK

NO0013457952

136 148 412

NOK 0.42

 

Governance

Nomination committee

The Articles of Association provide for a nomination committee composed of two or three members. The current members of the nomination committee are Bård Brath Ingerø (chair) and Grete Hogstad.

The nomination committee is responsible for nominating candidates for the election of shareholder-elected members and chairperson to the Board of Directors and for nominating members to the nomination committee, as well as making recommendations for remuneration of these.

For nomination committee please contact:
Bård Brath Ingerø, Chair of the Nomination Committee
+47 92 83 33 34 / bbi@reitenco.no

General meeting

2025

10 October 2025:

3 July 2025:

27 June 2025:

7 January 2025:

2024

17 July 2024: Observe Medical ASA – Minutes from Extraordinary General Meeting

26 June 2024: Observe Medical ASA – Notice of Extraordinary General Meeting

24 May 2024: Observe Medical ASA – Minutes from Annual General Meeting

3 May 2024: Notice of Annual General Meeting on 24 May 2024, including attendance, advance vote, and proxy forms

3 May 2024: Nomination Committee recommendation

3 May 2024: Observe Medical – Report of salary and other remuneration to leading personnel

2023

22 November 2023: Observe Medical ASA – Minutes Extraordinary General Meeting 

1 November 2023: Attendance and proxy form to the extraordinary general meeting

Shareholders who receive the notice by post with ref. no. and pin code can log in here and register either registration, proxy or advance votes

Shareholders who receive the notice electronically must log in to investor services (click on events, general meeting) for their registration

1 November 2023: Observe Medical ASA – Notice of Extraordinary General Meeting 22 November 2023

26 May 2023: Observe Medical ASA – Minutes from Annual General Meeting

26 May 2023: Represented List

5 May 2023:Notice of Annual General Meeting on 26 May 2023

5 May 2023: Notice of attendance and proxy form to the AGM on 26 May 2023

5 May 2023: VPS – Investor services

5 May 2023: Nomination Committee recommendation

5 May 2023: Observe Medical – Report of salary and other remuneration to leading personnel

 

2022

3 June 2022: Minutes from Annual General Meeting 2022

3 June 2022: Represented list

31 May 2022: Board of Directors recommendation for appointment of auditor

31 May 2022: The Nomination Committee recommendation part 2

13 May 2022: Notice of Annual General Meeting on 3 June 2022

13 May 2022: Notice of attendance and proxy form to the Annual General Meeting on 3 June 2022

13 May 2022: The Nomination Committee’s recommendation (part 1)

13 May 2022: Guidelines for determination of salary and other remuneration to executive personnel

13 May 2022: Report on salary and other remuneration to executive personnel year 2021

13 May 2022: VPS – Investor services

13 May 2022: LUMI

13 May 2022: Online guide LUMI (Norsk)

13 May 2022: Online guide LUMI (English)

4 February 2022: Minutes from Extraordinary General Meeting
4 February 2022: Represented list
14 January 2022: Notice of Extraordinary General Meeting on 4 February 2022
14 January 2022: Notice of attendance and proxy form to the Extraordinary General Meeting on 4 February 2022

 

2021

21 May 2021: Minutes from Annual General meeting
30 April 2021: Notice of Annual General Meeting on 21 May 2021

30 April 2021: Notice of attendance and proxy form to the Annual General meeting on 21 May 2021

30 April 2021: The Nomination Committee’s recommendation

30 April 2021: Guidelines for determination of salary and other remuneration to executive Personnel

 

2020

30 June 2020: Annual General Meeting

16 June 2020: Extraordinary General Meeting

9 June 2020: Notice of Annual General Meeting on 30 June 2020

9 June 2020: Attendance to the Annual General Meeting on 30 June 2020

9 June 2020: Recommendation by the Nomination Committee

9 June 2020: The Boards declaration on remuneration to executive management

26 May 2020: Notice of Extraordinary General Meeting on 16 June 2020

26 May 2020: Attendance to the Extraordinary General Meeting on 16 June 2020

 

2019

24 October 2019: Extraordinary General Meeting

1 October 2019: Extraordinary General Meeting

5 August 2019: Extraordinary General Meeting

Corporate Governance Principles
Instructions for the Nomination Committee
Transparency Act

IR contact

Jørgen Mann, Chief Executive Officer
+45 40 86 75 58 / jørgen.mann@observemedical.com

Johan M. Fagerli, Chief Financial Officer
+47 95 81 27 65 / johan.fagerli@observemedical.com

Sign up for the mailing list